APA (7th ed.) Citation

Sharma, M., Holmes, H. M., Mehta, H. B., Chen, H., Aparasu, R. R., Shih, Y. T., . . . Johnson, M. L. (2019). The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer, 125(7), 1155-1162. https://doi.org/10.1002/cncr.31917

Chicago Style (17th ed.) Citation

Sharma, Manvi, Holly M. Holmes, Hemalkumar B. Mehta, Hua Chen, Rajender R. Aparasu, Ya‐Chen T. Shih, Sharon H. Giordano, and Michael L. Johnson. "The Concomitant Use of Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: Prevalence, Predictors, and Impact on Survival and Discontinuation of Therapy in Older Adults with Cancer." Cancer 125, no. 7 (2019): 1155-1162. https://doi.org/10.1002/cncr.31917.

MLA (9th ed.) Citation

Sharma, Manvi, et al. "The Concomitant Use of Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: Prevalence, Predictors, and Impact on Survival and Discontinuation of Therapy in Older Adults with Cancer." Cancer, vol. 125, no. 7, 2019, pp. 1155-1162, https://doi.org/10.1002/cncr.31917.